The Measurement of Serum Transferrin and Ceruloplasmin in Patients with the Liver and Renal Diseases
Cheng Yingmei Hangzhou Sanitarium, PLA 310007
In this report, we have determined serum transferrin (TF) and ceruloplasmin (CP) in patients with liver and renal diseases. Results indicate that TF in all hepatitis groups are significantly lower than that in the nor- mal group. The TF level in patients with abnormal GPT and positive HBsAg are significantly lower than that in normal persons. Therefore, the TF level may be referred to as an index for the hepatitis prognosis. The TF level in nephropathy patients are also lower than that in normal persons. Contents of CP in each group are not similar, for example in patients with hepatic carcinous (52.44±8.73mg％) are significantly higher than that in the normal group (46.75±7.92mg％), but there is no significant difference between hepatic B and normal group. Contents of CP in hepatolenticular degeneration are significantly lower than that in normal group (P 0.001). Therefore, measurement of CP which provides an available objective index is helpful to distingulsh the hepatocirrhosis from liver carcinosis and hepatolenticular degeneration.